Literature DB >> 2437010

Monoclonal antibodies to human interferon-gamma. II: Antibodies with neutralizing activity.

Y Ichimori, N Suzuki, C Kitada, K Tsukamoto.   

Abstract

Two types of hybridomas secreting monoclonal antibodies (MAB) with neutralizing activity against human interferon-r (HuIFN-r) were obtained by somatic cell hybridization between mouse myeloma P3UI cells and spleen cells from BALB/c mice immunized with purified recombinant HuIFN-r and a conjugate of a synthetic amino-terminal peptide (residues 4-21) of HuIFN-r and bovine thyroglobulin. One of these MAB recognized the amino-terminal region (residues 4-21) of HuIFN-r, and the other recognized some region in the internal part (residues 22-130) of the molecule. These results suggest that another region, in addition to the amino-terminal region, contributed to the biological activity of rHuIFN-r. A combination of one of these MAB and a previously described MAB directed to the carboxyl-terminal region (residues 131-146) of HuIFN-r enables a quantitative and sensitive assay method of biologically active rHuIFN-r.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2437010     DOI: 10.1089/hyb.1987.6.173

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  4 in total

1.  High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy.

Authors:  N Suzuki; T Iwatsubo; A Odaka; Y Ishibashi; C Kitada; Y Ihara
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

2.  Recombinant human interferon-gamma. Differences in glycosylation and proteolytic processing lead to heterogeneity in batch culture.

Authors:  E M Curling; P M Hayter; A J Baines; A T Bull; K Gull; P G Strange; N Jenkins
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

3.  Development of a human gamma interferon enzyme immunoassay and comparison with tuberculin skin testing for detection of Mycobacterium tuberculosis infection.

Authors:  N Desem; S L Jones
Journal:  Clin Diagn Lab Immunol       Date:  1998-07

4.  Enhanced erythropoietin heterogeneity in a CHO culture is caused by proteolytic degradation and can be eliminated by a high glutamine level.

Authors:  M Yang; M Butler
Journal:  Cytotechnology       Date:  2000-10       Impact factor: 2.058

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.